Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Dec 20;10:85–94. doi: 10.2147/OTT.S113932

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Tang et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Survival curves plotted by employing Kaplan–Meier estimator.

Notes: (A) Kaplan–Meier plot with univariate analysis indicated that patients with low AZGP1 expression had a poor DSS (P<0.01) than those with normal AZGP1 expression, log-rank test. (B) A stratified survival analysis according to the pathological stage revealed that AZGP1 expression discernibility on DSS was only pronounced in patients with advanced clinical stage (stage I–II; P<0.001), log-rank test. (C, D) Kaplan–Meier plot with univariate analysis indicated that patients with low AZGP1 expression had a poorer local recurrence-free (P=0.016) and metastasis-free survival (P=0.014) than those with normal AZGP1 expression, log-rank test.

Abbreviation: DSS, disease-specific survival.